Astrazeneca Pharma India Ltd

NSE: ASTRAZEN BSE: 506820

₹8760

(-0.63%)

Fri, 13 Mar 2026, 06:07 am

MTF 5xInvest in Astrazeneca Pharma India Ltd with 5x Leverage Buy with MTF

Market Cap220.04B

PE Ratio109.01

Dividend0.37

Health Technology

Pharmaceuticals: Major

24.5K

Astrazeneca Pharma India EV/EBITDA Ratio

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	29.61	30.61	26.62	16.73	41.18	60.81	262.27	0	0	0	550.79	117.59	89.09	91.75	82.80	80.66	103.71	81.76	82.35	185.90
Price to book ratio	10.03	10.52	10.27	10.63	16.42	17.36	27.40	16.39	16.08	15.21	18.53	10.55	9.38	16.61	16.41	19.61	14.55	15.72	20.80	30.82
Price to sales ratio	5.66	5.53	5.38	3.49	5.98	6.57	9.51	4.19	5.83	4.89	5.13	4.33	4.06	6.86	7.19	9.31	7.93	8.09	10.27	12.54
Price to cash flow ratio	41.19	25.14	37.56	13.51	65.23	44.69	120.68	0	972.64	0	46.80	53.74	138.20	75.69	60.18	65.96	57.09	99.68	221.83	221.49
Enterprise value	12.08B	13.83B	15.25B	11.54B	23.06B	30.44B	51.35B	16.16B	26.71B	22.67B	28.15B	22.36B	21.9B	48.22B	57.38B	71.85B	59.49B	76.25B	128B	210.15B
Enterprise value to EBITDA ratio	19.65	19.16	16.91	10.25	25.70	36.69	114.81	0	0	0	168.15	59.71	44.76	67.12	47.01	54.18	67.31	45.59	68.56	81.55
Debt to equity ratio	0	0	0	0.54	0.01	0.05	0.01	0	0	0	0	0	0	0	0.03	0.03	0.02	0.01	0.01	0.05
Return on equity %	38.66	36.25	40.83	53.61	44.21	31.65	10.71	-61.95	-0.38	-12.93	3.43	10.58	12.12	19.88	21.71	24.94	14.97	20.79	27.95	17.31

Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio

The Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Astrazeneca Pharma India Ltd's valuation, profitability, and overall financial performance. Tracking the Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Astrazeneca Pharma India Ltd (NSE: ASTRAZEN, BSE: 506820) is currently trading at ₹8760, with a market capitalization of ₹220.04B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio Current Value

The current Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio stands at 81.55.

The latest Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

2024: 81.55
2023: 68.56
2022: 45.59
2021: 67.31
2020: 54.18

The recent rise in Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.

What Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Astrazeneca Pharma India Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800